SENTRY CAPGUARD nitenpyram tablet

国: アメリカ合衆国

言語: 英語

ソース: NLM (National Library of Medicine)

有効成分:

CAPGUARD™ Tablets contain 11.4 or 57.0 mg of nitenpyram, which belongs to thechemical class of neonicotinoids. Nitenpyram kills adult fleas.

から入手可能:

Sergeant's Pet Care Products Inc.

処方タイプ:

OTC

認証ステータス:

New Animal Drug Application

製品の特徴

SENTRY CAPGUARD- NITENPYRAM TABLET
SERGEANT'S PET CARE PRODUCTS INC.
----------
SENTRY CAPGUARD
SENTRY
CAPGUARD
(nitenpyram)
CAPGUARD™ is an oral tablet for dogs, puppies, cats and kittens 2
POUNDS OF BODY WEIGHT OR
GREATER AND 4 WEEKS OF AGE AND OLDER.
ACTIVE INGREDIENTS
CAPGUARD™ Tablets contain 11.4 or 57.0 mg of nitenpyram, which
belongs to the chemical class of
neonicotinoids. Nitenpyram kills adult fleas.
WARNINGS
Not for human use. Keep this and all drugs out of the reach of
children.
DIRECTIONS
CAPGUARD™ Tablets kill adult fleas and are indicated for the
treatment of flea infestations on dogs,
puppies, cats and kittens 2 POUNDS OF BODY WEIGHT OR GREATER AND 4
WEEKS OF AGE AND OLDER.
A single dose of CAPGUARD™ should kill the adult fleas on your pet.
If your pet gets re-infested
with fleas, you can safely give another dose as often as once per day.
To give CAPGUARD™ Tablets, place the pill directly in your pet’s
mouth or hide it in food. If you
hide the pill in food, watch closely to make sure your pet swallows
the pill. If you are not sure that your
pet swallowed the pill, it is safe to give a second pill.
Treat all infested pets in the household. Fleas can reproduce on
untreated pets and allow infestations to
persist.
DOS AGE
CAPGUARD™ Tablets should be administered according to the following
schedule. WEIGH YOUR PET
PRIOR TO ADMINISTRATION TO ENSURE PROPER DOSAGE. DO NOT ADMINISTER TO
PETS UNDER 2 POUNDS.
RECOMMENDED DOSAGE SCHEDULE
SPECIES
BODY WEIGHT
DOSE
NITENPYRAM PER
TABLET
Dog or Cat
2-25 lbs.
One tablet
11.4 mg
Dog
25.1-125 lbs.
One tablet
57.0 mg
ADVERSE REACTIONS
Pre-approval laboratory and clinical studies showed that CAPGUARD™
Tablets are safe for use in
dogs and cats, puppies and kittens 2 POUNDS OF BODY WEIGHT OR GREATER
AND 4 WEEKS OF AGE AND OLDER.
(SEE POST-APPROVAL EXPERIENCE SECTION).
®
™
POST-APPROVAL EXPERIENCE (REV. 2011):
The following adverse events are based on post-approval adverse drug
experience reporting. Not all
adverse reactions are reported to FDA CVM. I